赛伦生物
(688163)
| 流通市值：35.82亿 | | | 总市值：35.82亿 |
| 流通股本：1.08亿 | | | 总股本：1.08亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 79,084,602.67 | 188,857,056.89 | 52,641,806.22 | 33,284,505.89 |
| 交易性金融资产 | 644,969,430.12 | 553,591,881.97 | 712,149,071.23 | 764,909,182.18 |
| 应收票据及应收账款 | 95,519,340.22 | 92,140,745.64 | 55,440,604.59 | 46,098,142.29 |
| 其中：应收票据 | 18,688,199.02 | 15,942,093.06 | 6,256,927.8 | 10,036,552.63 |
| 应收账款 | 76,831,141.2 | 76,198,652.58 | 49,183,676.79 | 36,061,589.66 |
| 预付款项 | 476,354.07 | 579,587.43 | 79,285 | 87,156.35 |
| 其他应收款合计 | 1,163,117.05 | 1,264,851 | 1,235,867.96 | 902,207.94 |
| 存货 | 37,134,650.43 | 40,820,710.52 | 46,045,202.74 | 43,031,117.28 |
| 一年内到期的非流动资产 | 11,700,000 | 11,700,000 | 11,700,000 | 11,700,000 |
| 其他流动资产 | 11,882,871.46 | 11,765,425 | 12,080,712.9 | 12,149,399.6 |
| 流动资产合计 | 881,930,366.02 | 900,720,258.45 | 891,372,550.64 | 912,161,711.53 |
| 非流动资产: | | | | |
| 固定资产 | 103,335,821.57 | 105,776,573.36 | 108,614,931.59 | 111,983,906.37 |
| 在建工程 | 165,748,438.01 | 136,234,369.68 | 101,736,965.57 | 80,988,836.96 |
| 生产性生物资产 | 3,850,161.12 | 4,077,398.79 | 3,599,520.09 | 3,577,499.93 |
| 使用权资产 | 3,782,199.38 | 3,961,570.85 | 4,140,942.32 | 4,409,384.14 |
| 无形资产 | 21,888,487.36 | 22,082,760.32 | 22,277,649.56 | 22,472,538.8 |
| 长期待摊费用 | 214,743.93 | 274,730.67 | 334,717.41 | 394,704.15 |
| 递延所得税资产 | 7,261,929.97 | 7,597,541.75 | 7,381,326.31 | 6,885,710.68 |
| 其他非流动资产 | 4,125,911.3 | 3,353,738.93 | 14,913,607.45 | 14,336,114.68 |
| 非流动资产合计 | 310,207,692.64 | 283,358,684.35 | 262,999,660.3 | 245,048,695.71 |
| 资产总计 | 1,192,138,058.66 | 1,184,078,942.8 | 1,154,372,210.94 | 1,157,210,407.24 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 26,076,070.62 | 29,344,132.44 | 17,061,317.39 | 16,493,570.2 |
| 应付账款 | 26,076,070.62 | 29,344,132.44 | 17,061,317.39 | 16,493,570.2 |
| 合同负债 | 2,536,886.9 | 4,045,711.14 | 3,522,625.81 | 3,183,692.52 |
| 应付职工薪酬 | 7,888,763.88 | 6,612,978.03 | 8,153,343.9 | 11,533,685.2 |
| 应交税费 | 9,641,367.6 | 11,898,147.96 | 1,054,805.85 | 632,974.37 |
| 其他应付款合计 | 2,294,619.51 | 3,375,498.45 | 3,210,604.09 | 4,201,532.38 |
| 应付股利 | 26,700 | 25,500 | 22,900 | 22,900 |
| 一年内到期的非流动负债 | 743,581.21 | 743,581.21 | 767,626.86 | 767,626.86 |
| 其他流动负债 | - | - | - | 94,053.07 |
| 流动负债合计 | 49,181,289.72 | 56,020,049.23 | 33,770,323.9 | 36,907,134.6 |
| 非流动负债: | | | | |
| 租赁负债 | 3,844,915.8 | 4,138,537.62 | 4,176,440.31 | 4,327,823.52 |
| 预计负债 | 3,079,490.79 | 2,593,355.63 | 2,039,654.91 | 2,039,654.91 |
| 递延所得税负债 | 1,426,291.03 | 1,155,290.69 | 1,161,010.4 | 1,278,188.94 |
| 非流动负债合计 | 8,350,697.62 | 7,887,183.94 | 7,377,105.62 | 7,645,667.37 |
| 负债合计 | 57,531,987.34 | 63,907,233.17 | 41,147,429.52 | 44,552,801.97 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 108,220,000 | 108,220,000 | 108,220,000 | 108,220,000 |
| 资本公积 | 878,087,814.86 | 878,087,814.86 | 878,087,814.86 | 878,087,814.86 |
| 盈余公积 | 54,628,047.79 | 54,628,047.79 | 54,628,047.79 | 54,628,047.79 |
| 未分配利润 | 93,670,208.67 | 79,235,846.98 | 72,288,918.77 | 71,721,742.62 |
| 归属于母公司股东权益合计 | 1,134,606,071.32 | 1,120,171,709.63 | 1,113,224,781.42 | 1,112,657,605.27 |
| 股东权益合计 | 1,134,606,071.32 | 1,120,171,709.63 | 1,113,224,781.42 | 1,112,657,605.27 |
| 负债和股东权益合计 | 1,192,138,058.66 | 1,184,078,942.8 | 1,154,372,210.94 | 1,157,210,407.24 |
| 公告日期 | 2026-10-28 | 2026-08-22 | 2026-04-25 | 2026-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |